Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 3/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.35 |
| ▸ | F9 | P00740 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | CSF1R | P07333 | 1/20 | 0.33 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.33 |
| ▸ | LTK | P29376 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10411212 | 0.88 | — | — | |
| SCHEMBL16150637 | 0.87 | NOTUM (0.38) | ALDH1A1TNFFGFR1ACVR1 | |
| SCHEMBL5535527 | 0.82 | ABL1 (0.42) | ENPP1ALDH1A1HSD17B10HPGDMAPK1 | |
| SCHEMBL7754182 | 0.79 | KDM4E (0.37) | ALDH1A1HSD17B10HPGDMAPK1TNF | |
| SCHEMBL21351983 | 0.78 | — | — | |
| SCHEMBL9837227 | 0.78 | KDM4E (0.41) | ALDH1A1HSD17B10HPGDMAPK1TDO2 | |
| SCHEMBL2679046 | 0.76 | KDM4E (0.40) | ALDH1A1HSD17B10 | |
| SCHEMBL9050105 | 0.76 | TGFBR1 (0.41) | ALDH1A1MAPK14ACVR1 | |
| SCHEMBL11200488 | 0.75 | — | — | |
| SCHEMBL6487723 | 0.75 | LIMK1 (0.30) | LIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024117767-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-06-06 | — | — | WO | claimed |
| US-11873432-B2 | Luminescent materials including a luminescent benzothiazole, articles including a security feature, and methods of forming luminescent particles including a luminescent benzothiazole | HONEYWELL INTERNATIONAL INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-3887477-B1 | LUMINESCENT MATERIALS INCLUDING A LUMINESCENT BENZOTHIAZOLE, ARTICLES INCLUDING A SECURITY FEATURE, AND METHODS OF FORMING LUMINESCENT PARTICLES INCLUDING A LUMINESCENT BENZOTHIAZOLE | HONEYWELL INT INC (US) | 2024-01-03 | — | — | EP | claimed |
| US-20230043400-A1 | Compounds, Compositions and Methods | DENALI THERAPEUTICS INC. (US) | 2023-02-09 | — | — | US | claimed |
| EP-3887477-A1 | LUMINESCENT MATERIALS INCLUDING A LUMINESCENT BENZOTHIAZOLE, ARTICLES INCLUDING A SECURITY FEATURE, AND METHODS OF FORMING LUMINESCENT PARTICLES INCLUDING A LUMINESCENT BENZOTHIAZOLE | Honeywell International Inc. (US) | 2021-10-06 | — | — | EP | claimed |
| CN-113330093-A | Luminescent materials comprising luminescent benzothiazole, articles including security features, and methods of forming luminescent particles comprising luminescent benzothiazole | 霍尼韦尔国际公司 | 2021-08-31 | — | — | CN | claimed |
| US-20200317691-A1 | Compounds, Compositions and Methods | DENALI THERAPEUTICS INC. (US) | 2020-10-08 | — | — | US | claimed |
| US-20200172803-A1 | LUMINESCENT MATERIALS INCLUDING A LUMINESCENT BENZOTHIAZOLE, ARTICLES INCLUDING A SECURITY FEATURE, AND METHODS OF FORMING LUMINESCENT PARTICLES INCLUDING A LUMINESCENT BENZOTHIAZOLE | HONEYWELL INTERNATIONAL INC. (US) | 2020-06-04 | — | — | US | claimed |
| WO-2020113016-A1 | LUMINESCENT MATERIALS INCLUDING A LUMINESCENT BENZOTHIAZOLE, ARTICLES INCLUDING A SECURITY FEATURE, AND METHODS OF FORMING LUMINESCENT PARTICLES INCLUDING A LUMINESCENT BENZOTHIAZOLE | HONEYWELL INTERNATIONAL INC. (US) | 2020-06-04 | — | — | WO | claimed |
| EP-3414239-A2 | INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 | Denali Therapeutics Inc. (US) | 2018-12-19 | — | — | EP | claimed |
| US-10131676-B2 | Compounds, compositions and methods | DENALI THERAPEUTICS INC. (US) | 2018-11-20 | — | — | US | claimed |
| US-20180099981-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | DENALI THERAPEUTICS INC. | 2018-04-12 | — | — | US | claimed |
| US-9815850-B2 | Compounds, compositions and methods | DENALI THERAPEUTICS INC. (US) | 2017-11-14 | — | — | US | claimed |
| WO-2017136727-A2 | COMPOUNDS, COMPOSITIONS AND METHODS | DENALI THERAPEUTICS INC. (US) | 2017-08-10 | — | — | WO | claimed |
| US-8852755-B2 | Oxadiazole metallic complexes and their electronic and opto-electronic applications | MERCK PATENT GMBH (DE) | 2014-10-07 | — | — | US | claimed |
| US-4225682-A | PEPTIZED | DENKA CHEMICAL CORPORATION (US) | 1980-09-30 | — | — | US | claimed |
| WO-2024117767-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2024-06-06 | — | — | WO | disclosed |
| US-20240150376-A1 | Compounds, Compositions and Methods | DENALI THERAPEUTICS INC. (US) | 2024-05-09 | — | — | US | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3974170-A | SULFONATES, SULFINATES | MONSANTO COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180099981-A1 | COMPOUNDS, COMPOSITIONS AND METHODS | PIK3CA, PLK1, PIK3CB | LIMK1 554/4885ENPP1 900/4885F9 4574/4885 |
| US-20200317691-A1 | Compounds, Compositions and Methods | PIK3CA, PLK1, PIK3CB | LIMK1 554/4885ENPP1 900/4885F9 4574/4885 |
| US-20240150376-A1 | Compounds, Compositions and Methods | PIK3CA, PLK1, PIK3CB | LIMK1 554/4885ENPP1 900/4885F9 4574/4885 |
| US-10131676-B2 | Compounds, compositions and methods | PIK3CA, PLK1, PIK3CB | LIMK1 554/4885ENPP1 900/4885F9 4574/4885 |
| US-20230043400-A1 | Compounds, Compositions and Methods | PIK3CA, PLK1, PIK3CB | LIMK1 554/4885ENPP1 900/4885F9 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.